Zantac
Zantac Criteria
The criteria below is a list of standard filters. We can customize the criteria based on your requirements.
- Took brand-named Zantac (ranitidine)
- Diagnosed with one of the following cancers after taking Zantac
- Liver cancer
- Kidney cancer
- Bladder cancer
- Gastric cancer
- Esophageal cancer
- Stomach cancer
- Colon cancer
- Colorectal cancer
- Intestinal cancer
- Anal cancer
- Testicular cancer
- Pancreatic cancer
- Gallbladder cancer
- Other digestive tract cancer
- Not diagnosed with cancer prior to Zantac use
- No legal representation
Zantac Background Information
Over-the-Counter (OTC) Zantac
- 1993 – GSK and Warner Lambert enter joint venture for OTC Zantac
- 1995 – First approval of OTC Zantac
- 1998 – GSK and Warner Lambert split; WL takes Zantac trademark in the U.S.
- 2000 – Pfizer acquires Warner Lambert
- 2006 – Boehringer Ingelheim acquires OTC Zantac from Pfizer
- 2017 – Sanofi-AS acquires Zantac
Over-the-Counter (OTC) Zantac
- 1993 – GSK and Warner Lambert enter joint venture for OTC Zantac
- 1995 – First approval of OTC Zantac
- 1998 – GSK and Warner Lambert split; WL takes Zantac trademark in the U.S.
- 2000 – Pfizer acquires Warner Lambert
- 2006 – Boehringer Ingelheim acquires OTC Zantac from Pfizer
- 2017 – Sanofi-AS acquires Zantac
Case Option | Case Number | Date Filed | Count Filed In | Kind of Case | Alleged Injury (for PI) | Filing Firm |
---|---|---|---|---|---|---|
Galimidi vs. Sanofi US Services, Inc., et al. | 95707176 | 9/13/2019 | Circuit Court of the 11th Judicial Circuit In and For Miami-Dade County, Florida | Personal Injury | Breast Cancer (Male) | Levin Citron Rodal, PLLC |
Garza et al v. Sanofi-Aventis U.S. LLC et al | 5:19-cv-05772-BLF | 9/13/2019 | Northern District of California | Class Action | N/A | HAGENS BERMAN SOBOL SHAPIRO LLP |
Lopez Flores v. Sanofi US Services Inc. et al | 0:19-cv-62313-FAM | 9/17/2019 | Southern District of Florida | Personal Injury | Breast Cancer | Levin Citron Rodal, PLLC |
SANTORELLA et al v. SANOFI-AVENTIS U.S. LLC et al | 3:19-cv-18149 | 9/20/2019 | District of New Jersey | Class Action | N/A | HAGENS BERMAN SOBOL SHAPIRO LLP |
Dimesky et al v. Sanofi-Aventis U.S. LLC et al | 3:19-cv-01517 | 9/26/2019 | District of Connecticut | Class Action | N/A | HAGENS BERMAN SOBOL SHAPIRO LLP |
Kerzer v. Sanofi-Aventis U.S. LLC. et al | 1:19-cv-24092-RNS | 13/3/2019 | Southern District of Florida | Personal Injury | Kidney Cancer | COLSON HICKS EIDSON, P.A.; AYLSTOCK, WITKIN, KREIS & OVERHOLTZ, PLLC |
Hansen v.Boehringer Ingelheim Pharmaceuticals, Inc. et al | 2:19-cv-02069-KJM-AC | 10/15/2019 | Eastern District of California | Personal Injury | Colorectal Cancer | BAUM, HEDLUND, AEISTEI & GOLDMAN, P.C. |